FEMSelect Breaks into U.S. Market with AcuityMD to Speed Market Access for its Minimally Invasive Women’s Health Device
FEMSelect is leveraging AcuityMD’s platform to accelerate identification and engagement of U.S. physicians treating PFDs, which affect at least one in five women.